Table 3. Information on 16 patients who underwent genetic testing.

Patient	Diameter (cm)	Image characteristic	Pathological diagnosis	Group A	Group B
1	2.3	Solid	Adenocarcinoma	EGFR mutation
2	1.7	Solid	Adenocarcinoma		EGFR mutation
3	1.4	GGO	AAH	No mutant genes
4	2.0	Partial solid	Adenocarcinoma	EGFR mutation
5	2.3	GGO	Adenocarcinoma		No mutant genes
6	2.5	Solid	Adenocarcinoma		KRAS mutation
7	2.2	Solid	Adenocarcinoma	EGFR mutation
8	1.7	Solid	Indeterminate pathological diagnosis	No mutant genes
9	1.9	Partial solid	Adenocarcinoma	No mutant genes
10	1.5	GGO	AAH		No mutant genes
11	2.1	Partial solid	Adenocarcinoma	EGFR mutation
12	1.4	Partial solid	Indeterminate pathological diagnosis	No mutant genes
13	2.9	GGO	Adenocarcinoma	EGFR mutation
14	2.6	Solid	Adenocarcinoma	EGFR mutation
15	1.6	GGO	Adenocarcinoma	No mutant genes
16	2.2	Solid	Adenocarcinoma		EGFR mutation

AAH, atypical adenomatous hyperplasia; EGFR, epidermal growth factor receptor; GGO, ground-glass opacity; KRAS, Kirsten rat sarcoma viral oncogene.